Literature DB >> 10542397

Multimeric Coactivator Complexes for Steroid/Nuclear Receptors.

.   

Abstract

Nuclear receptors regulate transcription in direct response to their cognate hormonal ligands. Ligand binding leads to the dissociation of corepressors and the recruitment of coactivators. Many of these factors, acting in large complexes, have emerged as chromatin remodelers through intrinsic histone-modifying activities or through other novel functions. In addition, other ligand-recruited complexes appear to act more directly on the transcriptional apparatus, suggesting that transcriptional regulation by nuclear receptors might involve a process of both chromatin alterations and direct recruitment of key initiation components at regulated promoters.

Year:  1999        PMID: 10542397     DOI: 10.1016/s1043-2760(99)00208-8

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  5 in total

1.  p300 forms a stable, template-committed complex with chromatin: role for the bromodomain.

Authors:  E T Manning; T Ikehara; T Ito; J T Kadonaga; W L Kraus
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

2.  FTZ-Factor1 and Fushi tarazu interact via conserved nuclear receptor and coactivator motifs.

Authors:  C J Schwartz; H M Sampson; D Hlousek; A Percival-Smith; J W Copeland; A J Simmonds; H M Krause
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

3.  Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids.

Authors:  Sunil K Halder; Chakradhari Sharan; Omar Al-Hendy; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2014-06-12       Impact factor: 3.060

4.  Analysis of glucocorticoid and androgen receptor gene fusions delineates domains required for transcriptional specificity.

Authors:  D C Whitacre; K J Karnas; R L Miesfeld
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

Review 5.  Retinoids: novel immunomodulators and tumour-suppressive agents?

Authors:  M R Carratù; C Marasco; G Mangialardi; A Vacca
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.